GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadmon Holdings Inc (NAS:KDMN) » Definitions » PB Ratio

Kadmon Holdings (Kadmon Holdings) PB Ratio : (As of May. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Kadmon Holdings PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-14), Kadmon Holdings's share price is $9.50. Kadmon Holdings's Book Value per Share for the quarter that ended in Sep. 2021 was $-0.19. Hence, Kadmon Holdings's PB Ratio of today is .

The historical rank and industry rank for Kadmon Holdings's PB Ratio or its related term are showing as below:

During the past 7 years, Kadmon Holdings's highest PB Ratio was 56.22. The lowest was 0.00. And the median was 5.98.

KDMN's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.48
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Kadmon Holdings's average Book Value Per Share Growth Rate was -132.70% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Kadmon Holdings was 51.30% per year. The lowest was 51.30% per year. And the median was 51.30% per year.

Back to Basics: PB Ratio


Kadmon Holdings PB Ratio Historical Data

The historical data trend for Kadmon Holdings's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadmon Holdings PB Ratio Chart

Kadmon Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
PB Ratio
Get a 7-Day Free Trial - - 5.10 5.87 9.95

Kadmon Holdings Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.89 9.95 47.44 - -

Competitive Comparison of Kadmon Holdings's PB Ratio

For the Biotechnology subindustry, Kadmon Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kadmon Holdings's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadmon Holdings's PB Ratio distribution charts can be found below:

* The bar in red indicates where Kadmon Holdings's PB Ratio falls into.



Kadmon Holdings PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Kadmon Holdings's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2021)
=9.50/-0.186
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Kadmon Holdings  (NAS:KDMN) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Kadmon Holdings PB Ratio Related Terms

Thank you for viewing the detailed overview of Kadmon Holdings's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadmon Holdings (Kadmon Holdings) Business Description

Traded in Other Exchanges
N/A
Address
450 East 29th Street, New York, NY, USA, 10016
Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.
Executives
Harlan Waksal director, officer: President, CEO WAKSAL CONSULTING LLC, 7 NORTH WILLOW STREET, SUITE 6, MONTCLAIR NJ 07042
Nancy Miller-rich director C/O INTERCEPT PHARMACEUTICALS, INC., 10 HUDSON YARDS, 37TH FL, NEW YORK NY 10001
Cynthia Schwalm director C/O G1 THERAPEUTICS, 700 PARK OFFICES DR, SUITE 200, P.O. BOX 110341, RESEARCH TRIANGLE PARK NC 27709
Arthur S Kirsch director 7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4
David E Cohen director 3160 PORTER DRIVE, PALO ALTO CA 94304
Eugene Bauer director C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016
Tasos Konidaris director 103 JFK PARKWAY, SHORT HILLS NJ 07078
John L Ryan officer: Executive Vice President, CMO C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Steven Meehan officer: EVP, Chief Financial Officer 450 E. 29TH STREET NEW YORK NY 10016
Kyle Carver officer: Principal Accounting Officer, Controller 450 EAST 29TH STREET NEW YORK NY 10016
Gregory S. Moss officer: EVP, General Counsel, Chief Compliance Officer 450 EAST 29TH STREET, 16TH FLOOR, NEW YORK NY 10016
Perceptive Life Sciences Master Fund Ltd 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc other: Former 10% owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman 10 percent owner C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Steven N. Gordon officer: Exec VP, GC, Chief Admin, Comp C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016

Kadmon Holdings (Kadmon Holdings) Headlines

From GuruFocus

Kadmon to Present at Upcoming Investor Conferences

By ACCESSWIRE ACCESSWIRE 05-26-2021